AnaptysBio, Inc. (ANAB)

AnaptysBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	232.39	234.6	91.28	17.16	10.29	63.18
Revenue Growth	107.73%	157.01%	432.03%	66.78%	-83.72%	-15.77%
Cost of Revenue	128.78	135.97	163.84	132.28	88.8	98.5
Gross Profit	103.61	98.63	-72.56	-115.13	-78.51	-35.32
Selling, General & Admin	62.81	50.74	42.39	41.95	36.64	21.49
Operating Expenses	62.81	50.74	42.39	41.95	36.64	21.49
Operating Income	40.8	47.9	-114.95	-157.07	-115.15	-56.81
Interest Expense	-82.69	-79.89	-50.09	-18.08	-21.11	-1.45
Interest & Investment Income	11.74	13.5	19.79	18.87	7.55	0.43
Currency Exchange Gain (Loss)	5.43	5.43	0.01	-0	0.01	-
Other Non Operating Income (Expenses)	-1.9	-	-	-	-	0.04
EBT Excluding Unusual Items	-26.63	-13.07	-145.23	-156.28	-128.7	-57.8
Pretax Income	-26.63	-13.07	-145.23	-163.62	-128.7	-57.8
Income Tax Expense	0.16	0.16	0	-0	0.02	-
Net Income	-26.79	-13.23	-145.23	-163.62	-128.72	-57.8
Net Income to Common	-26.79	-13.23	-145.23	-163.62	-128.72	-57.8
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	28	29	28	27	28	27
Shares Outstanding (Diluted)	28	29	28	27	28	27
Shares Change	-3.66%	1.32%	5.42%	-4.41%	2.68%	0.47%
EPS (Basic)	-0.95	-0.46	-5.12	-6.08	-4.57	-2.11
EPS (Diluted)	-0.95	-0.46	-5.12	-6.08	-4.57	-2.11
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	4.41	19.61	-135.7	-121.61	-73.95	-47.29
Free Cash Flow Per Share	0.16	0.68	-4.78	-4.52	-2.63	-1.72
Gross Margin	44.58%	42.04%	-79.49%	-	-	-55.91%
Operating Margin	17.56%	20.42%	-125.93%	-915.50%	-1119.41%	-89.93%
Profit Margin	-11.53%	-5.64%	-159.11%	-953.66%	-1251.33%	-91.49%
Free Cash Flow Margin	1.90%	8.36%	-148.66%	-708.79%	-718.88%	-74.85%
EBITDA	41.34	48.46	-114.34	-156.42	-114.48	-56.2
EBITDA Margin	17.79%	20.65%	-125.27%	-	-	-88.95%
D&A For EBITDA	0.54	0.56	0.61	0.65	0.68	0.62
EBIT	40.8	47.9	-114.95	-157.07	-115.15	-56.81
EBIT Margin	17.56%	20.42%	-125.93%	-	-	-89.93%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error